An internally and externally validated nomogram to predict severe neutropenia in Japanese patients (pts) with advanced colorectal cancer (aCRC) treated with irinotecan (IRI)-based regimens.
Wataru Ichikawa
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Keisuke Uehara
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Keisuke Minamimura
Research Funding - Daiichi Sankyo
Chihiro Tanaka
Research Funding - Daiichi Sankyo
Yasumasa Takii
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Hideaki Miyauchi
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Sotaro Sadahiro
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Ken-ichi Fujita
Research Funding - Daiichi Sankyo
Toshikazu Moriwaki
Research Funding - Daiichi Sankyo
Masato Nakamura
Research Funding - Daiichi Sankyo
Takehiro Takahashi
Research Funding - Daiichi Sankyo
Akihito Tsuji
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Katsunori Shinozaki
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Satoshi Morita
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Other Remuneration - Daiichi Sankyo
Yuichi Ando
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Other Remuneration - Daiichi Sankyo
Yukihiro Okutani
Employment or Leadership Position - Daiichi Sankyo
Stock Ownership - Daiichi Sankyo
Masahiro Sugihara
Employment or Leadership Position - Daiichi Sankyo
Toru Sugiyama
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Yasuo Ohashi
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Yuh Sakata
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo